Pfizer Halts Development of Once-Daily Obesity Pill Following Liver Injury Reports
"That's disappointing news for those hoping for a pill option!"
"What will happen to the participants in the trials? Are they being monitored?"
"Pfizer needs to get it together. They can't afford many more setbacks."
"This is just one of many failures in the obesity drug market. What's next?"
"At least they are still pursuing other obesity treatments! That's a positive sign."
"Injectables are great but I really need an easy pill option!"
"Just imagine if they had released it without these issues! What a missed chance!"
"Pfizer has been struggling with new drug approvals lately. Time for a fresh strategy?"
"Why not collaborate with tech companies for better drug delivery systems?"
"I wonder how many people dropped out of the trial and why. That's critical info!"
"It's a shame because obesity is such a pressing issue, and we need better solutions."
2025-04-14T12:41:44.000Z
Hans Schneider
Source of the news: apnews.com